npressfetimg-3.png

Former ‘Jeopardy!’ host Mayim Bialik receives hyperbaric chamber treatment to address health issues – Fox News

health-and-well-being

Mayim Bialik Discusses Health Journey with Hyperbaric Oxygen Therapy

Mayim Bialik, the former host of “Jeopardy!”, has shared her health journey with her fans by announcing she will undergo hyperbaric oxygen therapy for the next six months. The 48-year-old actress expressed her health update in a candid Instagram post where she was seen posing inside a hyperbaric oxygen chamber.

“What on earth!?” Bialik captioned the Instagram post. “This is me in the Hyperbaric Oxygen (HBOT) chamber, choosing to cultivate an open mind about the numerous health benefits this treatment can provide.” She continued, “I’ll report back over the course of the next six months while this surprisingly roomy and actually not claustrophobia-inducing! chamber is my roomie.”

She also emphasized the importance of mental and physical health awareness, as she has previously done on her social media platforms and her “Mayim Bialik’s Breakdown” podcast. Last August, Bialik opened up about her hospital stay for a routine colonoscopy, using the opportunity to encourage others to keep up with preventative tests.

“It’s not terribly fun getting older,” Bialik admitted in her caption. “Especially when you have to get a routine colonoscopy and really wish you didn’t have to.” In a makeup-free hospital gown, she shared a video discussing the importance of talking about such topics because “if we don’t talk about them, it’s more likely that people don’t pay attention to certain aspects of our physical well-being, which is connected to our mental well-being.”

According to the CDC, it’s recommended that adults begin getting routine colonoscopies at age 45 or earlier if a person has inflammatory bowel disease or a family history of colon cancer or polyps.

Fox News Digital’s Emily Trainham contributed to this report. Stephanie Giang-Paunon is an Entertainment Writer for Fox News Digital, and story tips can be sent to [email protected] and on Twitter: @SGiangPaunon.